Literature DB >> 16618580

Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors.

Olivier Chapet1, Benedick A Fraass, Randall K Ten Haken.   

Abstract

PURPOSE: To evaluate whether increasing numbers of intensity-modulated radiation therapy (IMRT) fields enhance lung-tumor dose without additional predicted toxicity for difficult planning geometries. METHODS AND MATERIALS: Data from 8 previous three dimensional conformal radiation therapy (3D-CRT) patients with tumors located in various regions of each lung, but with planning target volumes (PTVs) overlapping part of the esophagus, were used as input. Four optimized-beamlet IMRT plans (1 plan that used the 3D-CRT beam arrangement and 3 plans with 3, 5, or 7 axial, but predominantly one-sided, fields) were compared. For IMRT, the equivalent uniform dose (EUD) in the whole PTV was optimized simultaneously with that in a reduced PTV exclusive of the esophagus. Normal-tissue complication probability-based costlets were used for the esophagus, heart, and lung.
RESULTS: Overall, IMRT plans (optimized by use of EUD to judiciously allow relaxed PTV dose homogeneity) result in better minimum PTV isodose surface coverage and better average EUD values than does conformal planning; dose generally increases with the number of fields. Even 7-field plans do not significantly alter normal-lung mean-dose values or lung volumes that receive more than 13, 20, or 30 Gy.
CONCLUSION: Optimized many-field IMRT plans can lead to escalated lung-tumor dose in the special case of esophagus overlapping PTV, without unacceptable alteration in the dose distribution to normal lung.

Entities:  

Mesh:

Year:  2006        PMID: 16618580     DOI: 10.1016/j.ijrobp.2005.12.028

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  4DCT-based measurement of changes in pulmonary function following a course of radiation therapy.

Authors:  Kai Ding; John E Bayouth; John M Buatti; Gary E Christensen; Joseph M Reinhardt
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

2.  Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.

Authors:  Xue-lian Du; Xiu-gui Sheng; Tao Jiang; Hao Yu; Yu-feng Yan; Rong Gao; Chun-hua Lu; Qing-shui Li
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

3.  Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.

Authors:  Diane C Ling; Clayton B Hess; Allen M Chen; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2015-08-03       Impact factor: 4.785

4.  Lung cancer: a 6-field technique using lateral beams in conformal radiotherapy for bilateral supraclavicular lymph node metastases.

Authors:  Shinichi Tsutsumi; Takuhito Tada; Tomoko Maekado; Masahiro Tokunaga; Noriko Tanaka; Ai Kobayashi; Eiichiro Okazaki; Shougo Matsuda; Masako N Hosono; Yukio Miki
Journal:  Springerplus       Date:  2014-12-13

5.  Why Do Both Mean Dose and V ≥x Often Predict Normal Tissue Outcomes?

Authors:  Lawrence B Marks; Stefan A Reinsberg; Ellen Yorke; Vitali Moiseenko
Journal:  Adv Radiat Oncol       Date:  2022-07-28

6.  Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature.

Authors:  Chance Matthiesen; Rajeev Ramgopol; Jonathan Seavey; Salahuddin Ahmad; Terence Herman
Journal:  Radiol Oncol       Date:  2012-01-02       Impact factor: 2.991

7.  Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.

Authors:  Erkan Topkan; Cem Parlak; Savas Topuk; Berrin Pehlivan
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

8.  CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer.

Authors:  Xiance Jin; Jinling Yi; Yongqiang Zhou; Huawei Yan; Ce Han; Congying Xie
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

9.  Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?

Authors:  Zhiqin Wu; Congying Xie; Meilong Hu; Ce Han; Jinling Yi; Yongqiang Zhou; Huawei Yuan; Xiance Jin
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.